Click here to download the August 2020 edition.
Navigating the EU’s Joint Clinical Assessment
Pathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be critical.
Navigating Cross-Border Pharma Deals: Key Trends and Lessons Out of China
The importance of a strategic approach and proper due diligence in unlocking the full potential of these arrangements.
Exploring Biopharma's Dealmaking Terrain, Roadmap in China
A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.
Pharma Forecasting: Key Markets Investors Can’t Ignore
The importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.
Passage to Asia: Early Access for Innovative Therapies
Pharma looks to take advantage of expanded access programs across Asia-Pacific region.
Global Expansion: Q&A with Mike Ryan
EVERSANA's Ryan discusses the company’s recent expansion into new markets in Europe.
